Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 38 619 | déclaré | 12 févr. 2023 | tx 11+412 352−4 768 |
| KalVista Pharmaceuticals, Inc. | 0 | déclaré | 11 juin 2026 | tx 31+151 250−429 385 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 11 juin 2026 | OTHER | KalVista Pharmaceuticals, Inc. | 59 291 | 0.00 USD | |
| 11 juin 2026 | OTHER | KalVista Pharmaceuticals, Inc. | 100 000 | — | deriv |
| 11 juin 2026 | OTHER | KalVista Pharmaceuticals, Inc. | 40 000 | — | deriv |
| 11 juin 2026 | OTHER | KalVista Pharmaceuticals, Inc. | 68 750 | — | deriv |
| 11 juin 2026 | OTHER | KalVista Pharmaceuticals, Inc. | 93 750 | — | deriv |
| 22 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5 000 | — | |
| 26 mai 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1 489 | 26.78 USD | |
| 22 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5 000 | 0.00 USD | deriv |
| 21 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | — | |
| 22 mai 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1 861 | 26.78 USD | |
| 21 mai 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | 0.00 USD | deriv |
| 16 avr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | — | |
| 17 avr. 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1 862 | 20.22 USD | |
| 16 avr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | 0.00 USD | deriv |
| 22 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5 000 | — | |
| 23 févr. 2026 | SALE | KalVista Pharmaceuticals, Inc. | 3 975 | 15.57 USD | |
| 21 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | — | |
| 22 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5 000 | 0.00 USD | deriv |
| 21 févr. 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | 0.00 USD | deriv |
| 16 janv. 2026 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 100 000 | 0.00 USD | deriv |
| 22 nov. 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5 000 | — | |
| 24 nov. 2025 | SALE | KalVista Pharmaceuticals, Inc. | 3 813 | 13.45 USD | |
| 21 nov. 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | — | |
| 22 nov. 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5 000 | 0.00 USD | deriv |
| 21 nov. 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6 250 | 0.00 USD | deriv |